MedTrace Logo

Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation

NCT05371470 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-03-19

No results posted yet for this study

Summary

The purpose of this study is to learn if a voice analysis smartphone app which detects anxiety and depression could be used along with cardiac rehabilitation to improve results compared to cardiac rehabilitation alone.

Conditions

Interventions

DEVICE

Ellipsis Health Voice Application

Smartphone application that utilizes voice biomarkers to assess for potential presence and severity of depression and anxiety

Sponsors & Collaborators

Principal Investigators

  • Virend Somers, MD, PhD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-21
Primary Completion
2026-11-30
Completion
2026-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05371470 on ClinicalTrials.gov